GSK and Verily Life Sciences(formerly Google Life Sciences) recently announced the creation of Galvani Bioelectronics which will realize the dream of creating bioelectronic therapeutics, truly ushering in the era of AI in human health solutions. At a cumulative investment of over US $ 700 million, this is a proverbial moon shot with an exciting array… Continue reading The perfect marriage of technology and therapeutics
Category: Personalized Medicine
Personalized medicine starts with the genetic code
One of the most exciting drugs of 2012 was VX-770 or Kalydeco, as it is commercially known developed by Vertex Pharmaceuticals. This drug was developed with strong support from the indomitable Cystic Fibrosis Foundation. In about 4-5% of cystic fibrosis patients, the G551D mutation, in the massive cystic fibrosis transmembrane conductance regulator gene (CFTR), leads… Continue reading Personalized medicine starts with the genetic code